Overexpression of PAK1 promotes endometrial cancer progression and cell proliferation (68) and previous studies have demonstrated that it is overexpressed in clinical samples of endometrial cancer when compared with normal endometrium (55). This evidence concerns the gene PAK1 and endometrial cancer.